Dear editor,
Injecting drug users (IDUs) are a population at increased risk of developing syphilis. In developing countries screening for syphilis is done by non-treponemal tests (VDRL/ RPR). Asymptomatic persons and patients with atypical presentations require conÞ rmation by treponemal tests like Treponema pallidum haemagglutination (TPHA). VDRL is a standardised, economical, sensitive and easy to perform test but one major problem with this test is that it is associated with false positive reactions. Foreign studies on IDUs have reported more than 10% incidence of false positive results. [1] There is paucity of similar studies in India. Therefore the present study was conducted to address this issue. Out of 150 serum samples tested, 6 (4%) were found to be reactive by VDRL test. The antibody titre was >8 in two (R32; R128) and <8 in the remaining four. TPHA test was reactive in 2(1.3%). These two TPHA reactive samples were also reactive in VDRL test in titre >8. Therefore, the www.ijmm.org prevalence of syphilis in IDUs on the basis of positive VDRL and TPHA test was 1.3% (2/150). This is lower than the prevalence rates reported in studies carried out in Delhi (6.09%), [2] Germany (3.3%) and Bangladesh (23%). [3] The possible explanation for this could be the difference in the subgroup of population studied and the diagnostic tests employed. In addition, region, gender, ethnic factors and socioeconomic factors which inß uence the development of sexual behaviour do play a big role in the prevalence of syphilis.
It has been reported that more than 10% of injecting drug users have false positive test results in titres >8.
[4] However, we observed false positive reactions in only 2.7% IDUs and that too in titre <8. The present study thus shows that in our Þ nancially constrained set-up VDRL test can be reliably employed for screening of IDUs. However, studies on larger scale are required to reach exact conclusion.
